Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Want to earn without upfront costs? Discover ways to earn today without any investment and start boosting your income now.
27,120 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
As quantum computers edge closer to practical power, Algorand faces a pivotal challenge. This article breaks down how...
People are embracing relaxed, outdoor-centered living. This article explores how casual nights outdoor spaces are cha...
Privacy-preserving crypto tools are meeting a hard policy edge. This article unpacks why developers feel at risk, wha...
Set a weekly ritual to translate headlines into a smarter portfolio. This Thursday reads guide shows you how to pick ...
When a high-flying IPO lands, the real work begins. Here are five practical milestones that space tech investors shou...
Want to protect cash flow while staying on the right side of the law? This guide shows real estate investors legally ...
When a CHH executive exercises stock options and sells shares ahead of retirement, it can raise questions for investo...
Begin your week with a curated set of investing insights. These 10 Monday reads turn market noise into concrete steps...
A new payment option is pushing into the spotlight without fanfare. Pay-by-bank quietly gaining ground challenges the...
A director at AMN Healthcare recently disclosed selling about 3,681 shares for roughly $114,000 as the stock jumped 4...
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...